JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) had the highest return between November 1, 2023 and January 1, 2024 by a US stock, returning 2,774.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
JIN MEDICAL INTERNATIONAL LTD Ordinary Shares (ZJYL) | 11/1/2023 - 1/1/2024 | 2,774.28% |
Regis Corporation Common Stock (RGS) | 11/1/2023 - 1/1/2024 | 1,332.25% |
Cardio Diagnostics (CDIO) | 11/1/2023 - 1/1/2024 | 721.78% |
Binah Capital Group, Inc Warrants (BCGWW) | 11/1/2023 - 1/1/2024 | 566.67% |
Direct Digital (DRCT) | 11/1/2023 - 1/1/2024 | 492.83% |
Hycroft Mining (HYMCW) | 11/1/2023 - 1/1/2024 | 455.32% |
QXO (QXO) | 11/1/2023 - 1/1/2024 | 443.17% |
Porch (PRCH) | 11/1/2023 - 1/1/2024 | 440.35% |
Mawson Infrastructure (MIGI) | 11/1/2023 - 1/1/2024 | 377.61% |
Altimmune (ALT) | 11/1/2023 - 1/1/2024 | 364.88% |
Incannex Healthcare Ltd ADR (IXHL) | 11/1/2023 - 1/1/2024 | 341.99% |
Shattuck Labs (STTK) | 11/1/2023 - 1/1/2024 | 340.12% |
Myomo (MYO) | 11/1/2023 - 1/1/2024 | 331.9% |
Anghami Inc Warrants (ANGHW) | 11/1/2023 - 1/1/2024 | 325.53% |
Mobix Labs (MOBXW) | 11/1/2023 - 1/1/2024 | 310.53% |
Ondas (ONDS) | 11/1/2023 - 1/1/2024 | 302.63% |
Frequency Therapeutics (KRRO) | 11/1/2023 - 1/1/2024 | 283.44% |
Gyre Therapeutics (GYRE) | 11/1/2023 - 1/1/2024 | 272.32% |
Lexaria Bioscience (LEXXW) | 11/1/2023 - 1/1/2024 | 267.65% |
Sky Harbour Group Corporation WT (SKYH.WT) | 11/1/2023 - 1/1/2024 | 266.93% |
Vivos Therapeutics (VVOS) | 11/1/2023 - 1/1/2024 | 265.88% |
Esperion Therapeutics (ESPR) | 11/1/2023 - 1/1/2024 | 260.76% |
Sera Prognostics (SERA) | 11/1/2023 - 1/1/2024 | 254.9% |
Eyepoint Pharmaceuticals (EYPT) | 11/1/2023 - 1/1/2024 | 249.09% |
C4 Therapeutics (CCCC) | 11/1/2023 - 1/1/2024 | 248.77% |
